Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation

Endocrinology

Volumn 144, Issue 1, 2003, Pages 346-352

  Lu, Huafei ^a   Kraut, Douglas ^a   Gerstenfeld, Louis C ^b   Graves, Dana T ^a  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CORE BINDING FACTOR; INSULIN; OSTEOCALCIN; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DLX5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MATRIX; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DISEASE MODEL; DROSOPHILA; HISTOPATHOLOGY; INSULIN TREATMENT; MESENCHYME; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; STREPTOZOCIN DIABETES; TREATMENT OUTCOME;

NON-PROGRAMMATIC;

ANIMALS; BONE DEVELOPMENT; BONE MARROW; CELL DIFFERENTIATION; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CORE BINDING FACTOR ALPHA SUBUNITS; CORE BINDING FACTORS; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; GENES, FOS; GENES, JUN; HOMEODOMAIN PROTEINS; INSULIN; MICE; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOCALCIN; TRANSCRIPTION FACTORS;

EID: 0037230153     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220072     Document Type: Article

References (29)

1. Levin M, Boisseau V, Avioli L 1976 Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med 294:241-245
2. Herskind A, Christensen K, Norgaard-Andersen K, Andersen JF 1992 Diabetes mellitus and healing of closed fractures. Diabetes Metab 18:63-64
3. Soejima K, Landing B 1986 Osteoporosis in juvenile-onset diabetes mellitus: Morphometric and comparative studies. Pediatr Pathol 6:289-299
4. Munoz-Torres M, Jodar E, Escobar-Jimenez F, Lopez-Ibarra P, Luna J 1996 Bone mineral density measured by dual x-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus. Calcif Tissue Int 58:316-319
5. Krakauer J, McKenna M, Burderer N, Rao D, Whitehouse F, Pafitt A 1995 Bone loss and bone turnover in diabetes. Diabetes 44:775-782
6. Topping R, Bolander M, Balian G 1994 Type X collagen in fracture callus and the effects of experimental diabetes. Clin Orthop 308:220-228
7. Funk J, Hale J, Carmines D, Gooch H, Hurwitz S 2000 Biomechanical evaluation of early fracture healing in normal and diabetic rats. J Orthop Res 18:126-132
8. Macey L 1989 Defects of early fracture-healing in experimental diabetes. J Bone Joint Surg Am 71:722-733
9. Goodman W, Hori M 1984 Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization. Diabetes 33:825-831
10. Verhaeghe J, Suiker A, Einhorn T, Geusens P, Visser W, Van Herck E, Van Bree R, Magitsky S, Bouillon R 1994 Brittle bone in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: Studies in diabetic and ovariectomized rats. J Bone Miner Res 9:1657-1667
11. Kawaguchi H, Kurokawa T, Hanada K, Hiyama Y, Tamura M, Ogata E, Matsumoto T 1994 Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135:774-781
12. Hough S, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL 1981 Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy. Endocrinology 108:2228-2234
13. Verhaeghe J, Suiker A, Visser W, Van Herck E, Van Bree R, Bouillon R 1992 The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats. J Endocrinol 134:485-492
14. Herold K, Vezys V, Sun Q, Viktora D, Seung E, Reiner S, Brown D 1996 Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J Immunol 156:3521-3527
15. Lukic M 1998 Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev Immunol 6:119-128
16. Mosci P, Vecchiarelli A, Cenci E, Puliti Ma, Bistoni F 1993 Low-dose streptozotocin-induced diabetes in mice. Cell Immunol 150:27-35
17. Kunjathoor V, Wilson D, LeBoeuf R 1996 Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97:1767-1773
18. Suva L, Seedor J, Endo E, Quartuccio H, Thompson D, Bab I, Rodan G 1993 Pattern of gene expression following rat tibial marrow ablation. J Bone Miner Res 8:379-388
19. Marusic A, Grcevic D, Katavic V, Lukic I, Kalajzic I, Lorenzo J 2000 Role of B lymphocytes in new bone formation. Lab Invest 80:1761-1774
20. Shimizu T, Mehdi R, Yoshimura Y, Yoshikawa H, Nomura S, Miyazono K, Takaoka K 1998 Sequential expression of bone morphogenetic protein, tumor necrosis factor, and their receptors in bone-forming reaction after mouse femoral marrow ablation. Bone 23:127-133
21. Miyama K, Yamada G, Yamamoto T, Takagi C, Miyado K, Sakai M, Ueno N, Shibuya H 1999 A BMP-inducible gene, Dlx5, regulates osteoblast differentiation and mesoderm induction. Dev Biol 208:123-133
22. Acampora D, Merlo G, Paleari L, Zerega B, Postiglione M, Mantero S, Bober E, Barbieri O, Simeone A, Levi G 1999 Craniofacial, vestibular and bone defects in mice laking the Distal-less-related gene Dlx5. Development 126:3795-3809
23. Ducy P, Zhang R, Geoffroy V, Ridall A, Karsenty G 1997 Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754
24. Ji C, Casinghino S, Chang D, Chen Y, Javed A, Ito Y, Hiebert S, Lian J, Stein G, McCarthy T, Centrella M 1998 CBFa(AML/PEBP2)-related elements in the TGF-β type I receptor promoter and expression with osteoblast differentiation. J Cell Biochem 69:353-363
25. Liang C, Barnes J, Seedor J, Quartuccio H, Bolander M, Jeffrey J, Rodan G 1992 Impaired bone activity in aged rats: Alterations at the cellular and molecular levels. Bone 13:435-441
26. Tanaka T, Barnes J, Liang C 1996 Effect of age on the expression of insulin-like growth factor-I, interleukin-6, and transforming growth factor b mRNAs in rat femurs following marrow ablation. Bone 18:473-478
27. Palcy S, Bolivar I, Goltzman D 2000 Role of activator protein-1 transcriptional activity in the regulation of gene expression by transforming growth factor β 1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells. J Bone Miner Res 15:2352-2361
28. McCabe L, Banerjee C, Kundu R, Harrison R, Dobner P, Stein J, Lian J, Stein G 1996 Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: Role of Fra-2 and Jun D during differentiation. Endocrinology 137:4398-4408
29. Ohta S, Hiraki Y, Shigeno C, Suzuki F, Kasai R, Ikeda T, Kohno H, Lee K, Kikuchi H, Konishi J 1992 Bone morphogenetic proteins (BMP-2 and BMP-3) induce the late phase expression of the protooncogene c-fos in murine osteoblastic MC3T3-E1 cells. FEBS Lett 314:356-360